Effect on quality of life of nCPAP treatment in patients with obstructive sleep apnea;Efecto del tratamiento con presión positiva continua en la vía respiratoria durante la noche en la calidad de vida de los pacientes con apnea del sueño

Medicina Clinica

Volumn 125, Issue 16, 2005, Pages 611-615

  Mar, Javier ^a   Rivero Arias, Oliver ^b   Durán Cantolla, Joaquin ^c   Alonso Álvarez, M Luz ^d   Gaminde, Idoia ^e   De La Torre Muñecas, German ^c  

^a Hospital Alto Deba   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^e Invest y Desarrollo Sanitarios   (Spain)

Author keywords

nCPAP; Obstructive sleep apnea; Quality of life; Treatment

Indexed keywords

ARTICLE; COHORT ANALYSIS; FOLLOW UP; HUMAN; INSTRUMENT; MAJOR CLINICAL STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP APNEA SYNDROME; TIME SERIES ANALYSIS;

EID: 28944432792     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080827     Document Type: Article

References (31)

1. Barbé F, Mayoralas L, Durán J, Masa JF, Maimó A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea without daytime sleepiness. A randomised controlled trial. Ann Intern Med. 2001;134:1015-23.
2. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84.
3. Terán-Santos J, Jiménez-Gómez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med. 1999;340:847-51.
4. Jenkinson C, Stradling J, Petersen S. How should we evaluate health status? A comparison of three methods in patients presenting with obstructive sleep apnoea. Qual Life Res. 1998;7:95-100.
5. Mar J, Rueda JR, Durán-Cantolla J, Schechter C, Chilcott J. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J. 2003; 21:515-22.
6. Tousignant P, Cosio MG, Levy RD, Groome PA. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep. 1994;17:52-60.
7. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR and the Clinical Significance Consensus Meeting Group. Mayo Clinic Proceedings. 2002;77:371-83.
8. Alonso J. La medida de la calidad de vida relacionada con la salud en la investigación y la práctica clínica. Gac Sanit. 2000;14:163-7.
9. Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evaluation. Health Technol Asses. 1999;3.
10. Kaplan RM, Anderson JP. The general health policy model: an integrated approach. En: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers; 1996. p. 309-22.
11. Feeny D, Furlong W, Boyle M, Torrance GW. Multiattribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7:490-502.
12. EuroQoL Group. EuroQoL - a new facility for measurement of health - related quality of life. Health Policy. 1990;16:199-208.
13. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Economics. 1996;5:141-54.
14. Ware JR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I conceptual framework and item selection. Med Care. 1992; 30:473-83
15. Brazier JE, Roberts JF, Deverill MD. The estimation of a preference based measure of health from SF-36. Health Economics. 2002;21:271-92.
16. Badía X, Roset M, Montserrat S, Herdman M y Segura A. (1999) La versión española del EuroQol: descripción y aplicaciones. Med Clin (Barc). 1999;112 Supl 1:79-86.
17. Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de los resultados clínicos. Med Clin (Barc). 1995;104:71-6.
18. Ferrer M, Vilagut G, Monasterio C, Montserrat JM, Mayos M, Alonso J. Medida el impacto de los trastornos del sueño: las versiones españolas del cuestionario del impacto funcional del sueño y de la escala de somnolencia de Epworth. Med Clin (Barc). 1999;113:250-5.
19. Weaver TE, Laizner AM, Evans LK, Maislin G, Chugh DK, Lyon K, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20:835-43.
20. Montserrat JM, Amilibia J, Barbé F, Capote F, Durán J, Mangado NG, et al. Tratamiento del sindrome de las apneas-hipopneas durante el sueno. Arch Bronconeumol. 1998;34:204-6.
21. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27:S178-89.
22. Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis. 1986;39:897-906.
23. Cohen J. Statistical power analysis for the behavioural sciences. New Jersey: Lawrence Earlbaum; 1998.
24. SPSS 12.0 Manual del usuario. Chicago: SPSS Inc.; 2003.
25. StataCorp. Stata Statistical Software: Release 8. College Station, TX: StataCorp LP.; 2003.
26. Ma G, Hall WJ. Confidence bands for the receiver operating characteristic curves. Med Decis Making. 1993;13:191-7.
27. Yang EH, Hla KM, McHorney CA, Havighurst T, Badr MS, Weber S. Sleep apnea and quality of life. Sleep. 2000;23:535-41.
28. Testa MA, Nackley JF. Methods for quality-of-life studies. Annu Rev Public Health. 1994;15:535-59.
29. Sprangers MA, Van Dam FS, Broersen J, Lodder L, Weber L, Visser MR. Revealing response shift in longitudinal research on fatigue. The use of then test approach. Acta Oncol. 1999;38:709-18.
30. Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol. 2002;41:229-37.
31. Stradling JR, Davies RJ. Sleep. 1: obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history. Thorax. 2004;59:73-8.